Reproduction and Obstetric Nursing Review

Reproductive System and Hormonal Cycles

  • Menstrual Cycle Hormonal Regulation

    • Menstrual Phase: Characterized by a decrease (\downarrow) in progesterone levels.

    • Follicular Phase:

      • Involvement of Follicle-Stimulating Hormone (FSHFSH).

      • Increase (\uparrow) in Estrogen levels triggers the Luteinizing Hormone (LHLH) surge.

    • Ovulation Phase: Occurs when LHLH and estrogen reach their peak levels.

    • Luteal Phase: Characterized by high levels of progesterone.

Methods of Contraception

  • Barrier and Mechanical Methods

    • Male and female condoms.

    • Diaphragm.

    • Cervical cap.

    • Sponge.

  • Hormonal and Long-Acting Methods

    • Combined Oral Contraceptive:

      • Contraindications: History of thromboembolism, Hypertension (HTNHTN), and migraines with aura.

    • Minipill: Progestin-only oral contraceptive.

    • Hormonal Intrauterine Device (IUD).

    • Copper IUD.

    • Depot medroxyprogesterone shot.

  • Permanent Methods

    • Male and female sterilization.

Infertility: Causes, Risk Factors, and Treatments

  • Pathological and Physiological Causes/Risk Factors

    • Polycystic Ovary Syndrome (PCOSPCOS).

    • Tubal blockage.

    • Endometriosis.

    • Uterine fibroids or polyps.

    • Abnormal sperm production or motility.

    • Age: Specifically women in their late 30s30s.

    • Body Mass Index (BMIBMI): Obesity or excessively low BMIBMI.

    • Medical treatments such as chemotherapy or radiation.

    • Substance use.

  • Assisted Reproductive Technologies (ART)

    • Intrauterine Insemination (IUI):

      • Procedure: Sperm is inserted directly into the uterus, closer to the egg, using a thin catheter.

      • Indications: Low sperm count, low sperm motility, and cervical deformities.

    • In Vitro Fertilization (IVF):

      • Procedure: A woman's egg and sperm are combined in a laboratory dish. The resulting embryo is then placed into the uterus to develop into a pregnancy.

      • Indications: Severe male infertility, unexplained infertility, failed alternative treatments, and tubal blockage.

  • Infertility Medications

    • Clomiphene citrate: Induces ovulation by blocking estrogen receptors; helps to regulate or restore ovulation.

    • Menotropin: Promotes ovarian follicular growth.

    • Follitropin: Stimulates follicles; specifically used for IVFIVF.

    • Human Chorionic Gonadotropin (hCG): Mimics the natural hormonal surge to mature eggs and trigger their release.

    • Metformin: Used to improve insulin resistance in cases of infertility specifically caused by PCOSPCOS.

Signs and Diagnosis of Pregnancy

  • Presumptive Signs (Subjective)

    • Amenorrhea: Absence of menstruation.

    • Excessive fatigue (Really tired).

    • Enlarged and sore breasts.

    • Increased frequency of urination.

    • Quickening: Perception of fetal movement by the mother.

    • Emesis (vomiting) and nausea.

  • Probable Signs (Objective indicators observed by an examiner)

    • Positive pregnancy test.

    • Ballottement: The returning of the fetus when the uterus is pushed with fingers.

    • Palpable outline of the fetus.

    • Braxton Hick’s contractions.

    • Goodell’s Sign: Softening of the cervix, occurring at approximately 686-8 weeks.

    • Chadwick’s Sign: Bluish coloration of the vulva, vagina, and cervix, occurring at approximately 44 weeks.

    • Hegar’s Sign: Softening of the lower uterine segment, occurring at approximately 6126-12 weeks.

    • Enlarged uterus.

  • Positive Signs (Definitive evidence of a fetus)

    • Fetal movement felt by an examiner.

    • Electronic device detection of heart tones.

    • The delivery of the infant.

    • Ultrasound detection of the baby.

    • Visible fetal movement.

Pregnancy Calculations and Clinical History

  • Naegele’s Rule (Estimating Due Date)

    • Formula: Month of LMP3 months+LMP day+7 days+1 year\text{Month of LMP} - 3 \text{ months} + \text{LMP day} + 7 \text{ days} + 1 \text{ year}.

    • Exception: If the Last Menstrual Period (LMPLMP) occurred in January, February, or March, do not add the extra year in the final step.

    • Example: LMPLMP is 12/10/202212/10/2022.

      • Month: 123=912 - 3 = 9

      • Day: 10+7=1710 + 7 = 17

      • Year: 2022+1=20232022 + 1 = 2023

      • Estimated Date of Delivery (EDDEDD): 9/17/20239/17/2023.

  • GTPAL Obstetric History

    • G (Gravida): Total number of pregnancies, regardless of outcome.

    • T (Term): Pregnancies delivered between 374037-40 weeks.

    • P (Preterm): Pregnancies delivered between 203620-36 weeks.

    • A (Abortions/Losses): Spontaneous or elective losses occurring prior to 2020 weeks.

    • L (Living): Number of currently living children.

High-Risk Pregnancy Factors

  • Genetic and History Factors

    • Family history of conditions like Cystic Fibrosis (CFCF) or Sickle Cell anemia.

    • Previous history of a high-risk pregnancy.

    • Pregnancies achieved with fertility assistance.

  • Age-Related Risks

    • Age >35: Increased risk for Preeclampsia (preEpre-E), Down syndrome, and late-term loss.

    • Age <18: Increased risk for Sexually Transmitted Infections (STISTI), premature birth, malnutrition, anemia, and Hypertension (HTNHTN).

  • Substance Use Risks

    • Small for Gestational Age (SGASGA).

    • Premature birth.

    • Fetal Alcohol Syndrome (FASFAS).

    • Developmental delays.

    • Stillbirths.

    • Neonatal Abstinence Syndrome (NASNAS) withdrawal.

Laboratory Tests and Diagnostics

  • Blood Work and Screening

    • Blood Type and Rh Factor (Type & Screen):

      • Rhogam: Administered at 2828 weeks gestation and within 7272 hours of delivering an Rh+Rh+ baby to an RhRh- mother.

    • STI Screening: Testing for Herpes Simplex Virus (HSVHSV), gonorrhea, and chlamydia.

    • RPR/VDRL: Specific screening for Syphilis.

    • Group B Streptococcus (GBS): Screened at 3636 weeks. If positive (++), requires IVIV antibiotics (Penicillin) during labor.

    • CBC/WBC: Complete Blood Count and White Blood Cell count.

    • Urinalysis (UA): Screened for the presence of protein.

  • Fetal Assessment

    • Ultrasound: Includes the Anatomy scan conducted at 2020 weeks.

    • Amniocentesis: Testing amniotic fluid for genetic conditions, fetal infections, or neural tube defects.

    • Alpha-Fetoprotein (AFP):

      • High (\uparrow) levels indicate potential Neural tube defects (e.g., Spina bifida).

      • Low (\downarrow) levels are associated with Down syndrome.

    • Non-stress Test (NST): Performed after 2828 weeks to test fetal Heart Rate (HRHR) in response to natural movements to gauge oxygenation and nervous system function.

Gestational Diabetes Screening

  • Glucose Tolerance Test (GTT): Conducted between 242824-28 weeks.

    • 1-hour screening: Blood sugar taken 11 hour after consuming a sugary drink.

      • Normal: < 140 \text{ mg/dL}.

      • Requires further testing: > 140 \text{ mg/dL}.

    • 3-hour screening: Requires a fasting baseline blood sugar, then consumption of a high-concentration glucose drink. Blood sugar is tested at 11, 22, and 33 hours after.

      • Diagnosis of Gestational Diabetes: Requires > 2 abnormal values based on the following reference ranges:

        • Fasting: 95 mg/dL\le 95 \text{ mg/dL}.

        • 1 hour: 180 mg/dL\le 180 \text{ mg/dL}.

        • 2 hour: 155 mg/dL\le 155 \text{ mg/dL}.

        • 3 hour: 140 mg/dL\le 140 \text{ mg/dL}.

Placental and Hypertensive Disorders

  • Placenta Previa

    • Pathology: The placenta covers the cervix.

    • Symptoms: Bright red blood; painless.

    • Management: Delivery via C-section; outpatient monitoring for active bleeding; transabdominal or transvaginal ultrasound; abstinence from intercourse or heavy activity.

  • Placenta Abruption

    • Pathology: The placenta separates from the uterine wall prematurely.

    • Symptoms: Painful; dark blood; uterine tenderness.

    • Management: This is an acute complication/emergency requiring an emergency C-section.

  • Hypertensive Disorders

    • Chronic HTN: Hypertension present before pregnancy or before 2020 weeks gestation; persists after 1212 weeks postpartum (PPPP).

    • Gestational HTN: Occurs after 2020 weeks and resolves after delivery.

    • Preeclampsia (> 20 weeks):

      • Signs/Symptoms: Blood Pressure (BPBP) above 140/90 mmHg140/90 \text{ mmHg}, proteinuria (++), edema, visual disturbances, Right epigastric pain (liver involvement indicated by elevated LFTsLFTs), pulmonary edema (crackles, Shortness of Breath), low urine output (monitored via BUNBUN and CreatinineCreatinine), and hyperreflexia (increased Deep Tendon Reflexes or DTRDTR).

      • Treatment:

        • Labetalol: Lowers Blood Pressure.

        • Magnesium Sulfate: Used for seizure prevention and fetal neuroprotection (reduces risk of cerebral palsy). Administered via loading and maintenance doses.

        • Magnesium Toxicity Signs: Lethargy, urine output < 30 \text{ mL}, Deep Tendon Reflexes at 00, and altered mental status. Antidote: Calcium gluconate.

    • Eclampsia: Emergency characterized by seizures. Management includes preventing aspiration, addressing high BPBP, and proceeding to delivery.

    • HELLP Syndrome: Characterized by Hemolysis (HH), Elevated Liver enzymes (ELEL), and Low Platelets (LPLP). Carries risks of organ damage and hemorrhage.

Labor Complications and Management

  • Uterine and Labor Progress Issues

    • Tachysystole: More than 55 contractions in a 1010-minute period. Risks include placental abruption, postpartum hemorrhage, or fetal hypoxia. Management: Discontinue Pitocin, place mother in left lateral position, administer IVIV fluids and oxygen.

    • Precipitous Labor: Delivery within 33 hours. Risks include maternal lacerations, placental abruption, postpartum hemorrhage, fetal hypoxia, and fetal injury.

    • Labor Dystocia ("Failure to Progress"): Risks for infection and neonatal sepsis. Management: Pitocin administration, Artificial Rupture of Membranes (AROMAROM), operative or cesarean delivery.

  • Fetal Presentation and Infection

    • Breech: Baby is positioned bottom or feet first. Requires C-section.

    • Fetal Position:

      • Occiput Posterior: More painful, tighter fit, higher risk for injury.

      • Occiput Anterior: The desired position.

    • Chorioamnionitis: Infection of the amniotic fluid.

      • Signs/Symptoms: Maternal fever, tachycardia (maternal or fetal > 160 \text{ bpm}), uterine tenderness, and itchy palms.

      • Treatment: Broad-spectrum antibiotics and drawing bile acids.

      • Risk Factors: Prolonged rupture of membranes and frequent cervical exams (increased bacteria exposure).

  • Abortion Classifications

    • Spontaneous Abortion: Occurs after early initiation of labor without illness. Causes include infections, organisms in the lower genitals, or periodontal disease.

    • Indicated Abortion: Causes include gestational diabetes, HTNHTN, preeclampsia, obstetric disorders, advanced maternal age, polyhydramnios, or oligohydramnios.

Clinical Assessment of Labor

  • Suspected Labor Tests

    • Preterm Screening: Fetal fibronectin (fFNfFN) swab of the cervix. Requires nothing in the cervix for at least 2424 hours prior.

    • Dilation: Measurement of how wide the cervix has opened (010 cm0-10 \text{ cm}).

    • Effacement: Measurement of how thin the cervix is (0100%0-100 \text{\%}).

    • Station: Position of the baby's head relative to the ischial spines on the pelvis.

      • Negative (-) Station: Above the ischial spine. Warning: Do not rupture membranes if station is too high, as the gush of fluid can cause Cord Prolapse.

      • Cord Prolapse Management: Push the baby's head up to decompress the cord.

      • Positive (++) Station: Below the ischial spine.

  • Fetal Distress and Size Issues

    • Meconium Aspiration: Fetus has a bowel movement in utero, staining amniotic fluid dark green or yellow.

    • Macrosomia (> 4000 \text{ g}): Also known as Large for Gestational Age (LGALGA).

      • Risks: Shoulder dystocia, maternal tears, and neonatal hypoglycemia (shaking, lethargy, poor appetite).

      • Hypoglycemia Treatment: Glucose gel and re-feeding.

    • Shoulder Dystocia:

      • Signs/Symptoms: Clavicular fracture, weak reflex, brachial plexus injury.

      • Risk Factors: Fetal placement, LGALGA, previous shoulder dystocia, cephalopelvic insufficiency, and post-term baby.

      • Treatment Positions: McRoberts position (knees to chest), all fours position, and suprapubic pressure.

Labor Monitoring and Contractions

  • Monitoring Tools

    • Tocodynamometer: External sensor strapped to the abdomen.

    • Intrauterine Pressure Catheter (IUPC): Small catheter inserted into the uterus for internal monitoring.

  • Contraction Parameters

    • Frequency: The time from the onset of one contraction to the onset of the next.

    • Duration: The time from the onset of one contraction to the end of the same contraction.

    • Intensity: Measured by subjective palpation.

Fetal Heart Rate (FHR) Patterns

  • Variable Deceleration: Caused by cord compression.

    • Management: Discontinue Pitocin, change maternal position (feet to head), administer oxygen; C-section is probable.

  • Early Deceleration: Caused by head compression.

    • Management: Sign of labor progress; continue to monitor.

  • Acceleration: Sign of a healthy fetus.

  • Late Deceleration: Caused by placental perfusion insufficiency.

    • Management: Discontinue Pitocin, place in lateral side position, administer oxygen, increase IVIV fluids, and palpate for tachysystole.

Mechanics of Labor

  • Fetal Movements and Preparation

    • Kick Count: If decreased, the mother should drink a sugary drink (e.g., Orange Juice), count after a meal or in the evening, and focus on achieving 1010 movements within 22 hours.

    • Braxton Hicks Contractions: Felt in the upper abdomen; localized cramping; usually dissipate with activity.

    • True Contractions: Characterized by a squeezing sensation that is painful and wraps around the entire uterus.

  • The Birthing Process

    • Labor Pushing: Typically involves 33 pushes and deep breaths per contraction.

    • Ferguson’s Reflex: The natural urge to bear down caused by pressure from the baby’s head.

Stages of Labor

  • Stage 1: Dilation and Effacement

    • Contains three phases: Latent, Active, and Transition.

    • Goal: Cervical dilation from 010 cm0-10 \text{ cm} and 100%100 \text{\%} effacement.

    • Phase 1: Latent

      • Dilation: 14 cm1-4 \text{ cm}.

      • Contractions: Every 5305-30 minutes, lasting 304530-45 seconds. Mild intensity.

      • Duration: Longest phase for first-time mothers (> 14 \text{ hours}).

      • Recommendation: Stay home until active labor or water breaks.

    • Phase 2: Active

      • Dilation: 47 cm4-7 \text{ cm}.

      • Contractions: Every 353-5 minutes, lasting 456045-60 seconds.

      • Duration: 48 hours4-8 \text{ hours}. Water usually breaks.

    • Phase 3: Transition

      • Dilation: 810 cm8-10 \text{ cm}.

      • Contractions: Intense, back-to-back (every 232-3 minutes), lasting 609060-90 seconds.

      • Duration: 30 minutes30 \text{ minutes} to 2 hours2 \text{ hours}.

  • Stage 2: Delivery of the Baby

    • Starts at full dilation (10 cm10 \text{ cm}) and ends with delivery.

    • Crowning: Fetal station at +1+1 to +5+5.

  • Stage 3: Delivery of the Placenta

    • Ends with the full delivery of the placenta; lasts 5155-15 minutes.

    • Cord Care: Clamp cord twice, wait for pulsing to stop, cut in the middle. Gentle traction used.

    • Placenta Sides: "Dull" is the mother’s side; "Shiny" is the baby’s side.

  • Stage 4: Postpartum Recovery

    • 14 hours1-4 \text{ hours} post-delivery. Monitoring Vital Signs (BPBP, HRHR, temp) and fundal firmness/position.

Postpartum Complications

  • Uterine Atony

    • Signs/Symptoms: Boggy (soft) uterus, displaced uterus, excessive bleeding, decreased BPBP, tachycardia.

    • Risk Factors: Full bladder, multiple gestations, gestational diabetes, polyhydramnios, fetal macrosomia, retained placenta, tocolytics, or infection.

    • Treatment: Empty the bladder, fundal massage, medications (Oxytocin, Carboprost, Misoprostol, Methylergonovine), surgery, or blood transfusion.

  • Lacerations

    • Signs/Symptoms: Localized pain, tenderness, redness, swelling, irritation, or visible tear.

    • Treatment: Ice for the first 2424 hours, sitz baths, pericare, and stool softeners.

  • Hematoma

    • Localized collection of blood under skin. Signs include pressure, excessive bleeding, and bluish bruising.

    • Treatment: Ice, non-opioid pain meds, and drainage.

Postpartum Assessment and Care

  • Breasts: Mastitis vs. Engorgement

    • Mastitis: Infection or clogged duct (usually one breast). Painful, warm, red, with flu-like symptoms. Treatment: Antibiotics, continue breastfeeding, and pain relievers.

    • Engorged Breast: Affects both breasts; they feel hard and firm. Treatment: Warm compresses, cool packs, use of a lactation consultant.

  • Physical Monitoring

    • Uterus: Check for firmness (firm vs. boggy) and location (midline to umbilicus).

    • Bladder: Monitor for distention or inability to void.

    • Bowel: Assess sounds and prevent constipation with stool softeners.

    • Lochia (Discharge):

      • Rubra: Bright red (days 141-4).

      • Serosa: Pink/brown (days 4104-10).

      • Alba: White/yellow (after day 1010).

      • Alert: Saturated pad in < 15 \text{ minutes} or large clots.

    • REEDA Scale (for lacerations/episiotomy): Redness, Edema, Ecchymosis, Drainage, Approximation.

  • Postpartum Mental Health

    • Baby Blues: Very common; occurs 232-3 days postpartum; resolves within 22 weeks.

    • Postpartum Depression: Occurs weeks to months later; persistent sadness and hopelessness.

    • Postpartum Anxiety: Excessive worry about the baby.

    • Postpartum Psychosis: Typically 22 days to 66 weeks postpartum; hallucinations/delusions; psychiatric emergency.

Neonatal Considerations

  • Thermoregulation

    • Evaporation: Heat loss when moisture from amniotic fluid evaporates. Prevention: Dry the baby immediately.

    • Conduction: Heat loss or gain via skin-to-skin contact.

Comprehensive Medication Summary

  • Oxytocin (IVIV): Stimulates uterine contractions to induce or speed up labor.

  • Magnesium Sulfate (IVIV): Used for fetal neuroprotection and maternal seizure prevention.

  • Betamethasone (IMIM): Administered in 22 doses, 1212 hours apart to promote fetal lung maturation.

  • Rhogam: Prevents RhRh incompatibility; given at 2828 weeks and after delivery if baby is Rh+Rh+ status.

  • Labetalol (POPO): Antihypertensive for gestational hypertension.

  • Hydralazine (IVIV): Short-term management for severe pre-eclampsia/eclampsia.

  • Penicillin (IVPIVP): Antibiotic given if mother is GBS+GBS+ to protect the newborn.

  • Morphine (IVIV): Pain management in early labor; avoided in active labor to prevent respiratory distress in the neonate.

  • Misoprostol (POPO): Softens the cervix and stimulates contractions.

  • Terbutaline (SQSQ): Delays preterm contractions or manages tachysystole by relaxing the uterus.

  • Dinoprostone: Softens, thins, and opens the cervix for induction.